Creator of Diabetes Health Magazine, Scott King, has been a type 1 diabetic for over 34 years. Needless to say, he knows diabetes, and he is doing a remarkable job of introducing cutting-edge treatments for diabetics. In the first Diabetes Health TV broadcast, he shared interviews from the recent AADE Conference. A really exciting product he featured is called Neuragen - a topical treatment for diabetes neuropathy.

With diabetes neuropathy, people experience pain due to damage to the peripheral nerves. Neuropathic pain is often characterized by burning sensations or shooting pain, or may occur as numbness or chronic itching. Clinical trials have shown Neuragen to be effective in 70% of patients for the pain associated with diabetes. The ingredients are pretty kosher, too. Neuragen is made of a proprietary blend of essential oils from special species of geranium, lavender, bergamot, eucalyptus, and tea tree.

The Neuragen rep was blunt when he described the effective nature of this all natural product - using more does not make it any more effective! You have to admire his refreshing honesty. But like I said upfront - if Scott King is willing to spend the time getting the scoop on this product - it's probably worth your time using it. For more interviews, checkot the full coverage of the AADE Conference on Diabetes Health TV!

The American Association of Diabetes Educators has spent big bucks this year ensuring its point of view gets across to our representatives in the federal government. The AADE spent $375,000 on lobbying in just the first half of 2007, according to a Senate disclosure form that has been picked up by the media. The law requires that such disclosures be made public. Members of the organization include big Pharma names like Eli Lilly, Novartis and Merck.

The AADE is, obviously, a member organization for diabetes educators, with advocacy in Washington - for professionals and patients - coming as an additional service. The government-run site Healthfinder lists more about the AADE if you're interested. Given the amount of money involved, I'm surprised how little attention this has attracted on the Web. Many news services have featured the disclosure, but only in brief. What I'd like to know is: what issues were the AADE lobbying for and against?

In 2005, Omron Healthcare presented the Motivate, Monitor and Measure session at the annual meeting of the American Association of Diabetes Educators. At the conference, specialists spoke about weight management as it relates to diabetes, hypertension and overall wellness. Omron wanted to focus on the importance of motivating to increase activity, monitoring the response and measuring the outcomes.

People with diabetes are faced with a greater risk of developing high blood pressure and heart disease. Omron's commitment to raising awareness about blood pressure, weight and exercise programs is evidenced by the engineering that makes their products among the best in the market for their ease of use and accuracy.

Omron Healthcare's products were used during the presentation to show how patients can motivate themselves and monitor their walking with the HJ-112 Premium Pedometer, as well as monitor and measure their blood pressure with the HEM-780 Automatic Blood Pressure Monitor, equipped with the ComFit Cuff, which fits arms 9 to 17 inches, the only cuff which is applicable to 97% of the US adult population and proven to be accurate for obese individuals and the HEM-637 Wrist Blood Pressure Monitor outfitted with Automatic Positioning Sensor (A.P.S.), which detects the position of the wrist and guides it to the heart level by sound and display on the monitor. The product lineup has all the whistles and bells a person needs to be motivated to monitor and measure. After all - it's your health we're talking about!